ImpediMed Limited IPDQF
$0.01
$0.0040.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.16% | 20.39% | 20.60% | 20.21% | 21.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.16% | 20.39% | 20.60% | 20.21% | 21.55% |
| Cost of Revenue | 9.65% | 22.90% | 37.65% | 33.54% | 30.89% |
| Gross Profit | 20.68% | 20.02% | 18.26% | 18.33% | 20.19% |
| SG&A Expenses | 2.94% | 6.79% | 9.93% | 3.97% | -0.18% |
| Depreciation & Amortization | -4.06% | 11.90% | 32.21% | 58.16% | 99.87% |
| Other Operating Expenses | 22.11% | -17.76% | -40.88% | -32.42% | -19.20% |
| Total Operating Expenses | 4.04% | 5.27% | 5.59% | 4.87% | 5.62% |
| Operating Income | 4.31% | 2.83% | 2.20% | 2.53% | 1.51% |
| Income Before Tax | -11.30% | -12.27% | -12.26% | -13.20% | -15.87% |
| Income Tax Expenses | 3.57% | 11.04% | 17.61% | -5.85% | -22.22% |
| Earnings from Continuing Operations | -11.30% | -12.27% | -12.27% | -13.18% | -15.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.30% | -12.27% | -12.27% | -13.18% | -15.81% |
| EBIT | 4.31% | 2.83% | 2.20% | 2.53% | 1.51% |
| EBITDA | 4.15% | 2.56% | 2.59% | 5.57% | 7.18% |
| EPS Basic | -5.41% | -9.86% | -14.71% | -15.15% | -15.63% |
| Normalized Basic EPS | -2.13% | -6.67% | -11.63% | -6.82% | -6.82% |
| EPS Diluted | -5.41% | -9.86% | -14.71% | -15.15% | -15.63% |
| Normalized Diluted EPS | -2.13% | -6.67% | -11.63% | -6.82% | -6.82% |
| Average Basic Shares Outstanding | 5.70% | 2.88% | 0.07% | -0.03% | -0.13% |
| Average Diluted Shares Outstanding | 5.70% | 2.88% | 0.07% | -0.03% | -0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |